Healthcare Facilities / Services
Cryo Save Group NV Appoints Walter van Pottelberge As Chairman To Replace Johan Goossens-DJ
Dow Jones reported that Cryo Save Group NV has appointed Non-Executive Director Mr. Walter van Pottelberge as Chairman. Mr. van Pottelberge is to replace Mr. Johan Goossens.
Feelgood Svenska AB Acquire Hagabadet Holding AB
Feelgood Svenska AB announced that the Company has signed an agreement with Mr. Per-Olof Johansson, Managing Director of Hagabadet AB, a half owned subsidiary of Hagabadet Holding AB, and with Ms. Helene Johansson on the purchase of all shares in Hagabadet Holding AB for SEK 0.3 million in cash. The acquisition will take place on June 1, 2013. Hagabadet is active within the fields of baths, day-spa, fitness and restaurants & conferences.
Primary Health Properties PLC Announces Proposed Firm Placing And Placing, Open Offer
Primary Health Properties PLC announced a share issue to raise gross proceeds of up to GBP60.0 million (approximately GBP58.0 million net of expenses) through the issue of up to 19,047,618 new Ordinary Shares by way of a Firm Placing and Placing, Open Offer and Offer for Subscription at a price of 315 pence per New Share. The Issue Price represents a discount of 6.3 per cent. to the Closing Price of 336.25 pence per Ordinary Share on May 21, 2013. Issue of 7,301,587 new Ordinary Shares through a Firm Placing raising gross proceeds of GBP23.0 million. The Firm Placing is underwritten by Numis and Peel Hunt. Issue of up to 11,746,031 new Ordinary Shares pursuant to a Placing, Open Offer and Offer for Subscription to raise gross proceeds of up to GBP37.0 million. Qualifying Shareholders are being offered the opportunity to participate in the Open Offer on the basis of 1 Open Offer Share for every 10 Existing Ordinary Shares. qualifying Shareholders are also being offered the opportunity to subscribe for New Shares in addition to their Basic Entitlements under the Excess Application Facility. The Board has the ability to increase the size of the Capital Raising by up to 25 per cent should there be sufficient demand so that the gross proceeds would be approximately GBP75.0 million
Mediclinic International Ltd Announces Cash Dividend
Mediclinic International Ltd announced that the Directors have declared a final gross cash dividend in respect of the year under review of 60.5 cents (2012: 55.0 cents) (51.4250 cents (2012: 46.7500 cents) net of dividend withholding tax) per ordinary share. The dividend declared increased by 10% compared to the comparative period. The record date is on June 21, 2013 and the payment date is on June 24, 2013.
Generation Healthcare REIT Announces Completion Of $15.1 Million Entitlement Offer
Generation Healthcare REIT announced the completion of its three for 16 pro rata non-renounceable entitlement offer of new GHC units to existing GHC investors at an offer price of $0.97 per New Unit. The Entitlement Offer opened on May 7, 2013 and closed on May 20, 2013. Normal trading in the New Units is expected to commence on May 28, 2013.
Concord Medical Services Holdings Ltd Reaffirms FY 2013 Revenue Guidance
Concord Medical Services Holdings Ltd announced that for fiscal 2013, it expects to generate total net revenues in an estimated range of RMB930 million to RMB975 million. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of CNY934 million for fiscal 2013.
Interleukin Genetics Inc Announces $12 Million Private Placement
Interleukin Genetics Inc announced that it has raised $12.0 million in gross proceeds through a private placement of its securities to accredited investors. Interleukin sold an aggregate of 43,715,847 shares of its common stock at a price of $0.2745 per share and issued warrants to purchase an aggregate of 32,786,885 shares of common stock at an exercise price of $0.2745 per share to the investors. Subject to future approval by Interleukin`s shareholders of an increase in the number of authorized shares of common stock, each investor has the right, prior to June 30, 2014, to purchase its pro rata share of up to an aggregate of $5,000,000 of additional shares of common stock and warrants on the same terms and conditions as those set forth above. Immediately prior to the closing of this transaction Pyxis Innovations Inc., the sole holder of Interleukin`s Series A-1 Preferred Stock, converted all outstanding shares of Series A-1 Preferred Stock into 28,160,200 shares of common stock and converted all of Interleukin`s outstanding convertible debt ($14,316,255) into 2,521,222 shares of common stock. BTIG, LLC acted as the exclusive placement agent for the transaction.
Apollo Hospitals Enterprise Ltd's Board Recommends Dividend
Apollo Hospitals Enterprise Ltd announced that the Board of Directors of the Company at its meeting held on May 20, 2013, inter alia, has recommended a dividend of INR5.50 per share (110% of the face value of the share) for the financial year ended March 31, 2013, on the paid up equity capital of the Company. The dividend, if declared, will be paid on or before August 17, 2013.
Netcare Ltd Announces Interim Dividend
Netcare Ltd announced a gross interim dividend of 27.0 cents per ordinary share in respect of the six months ended March 31, 2013 has been declared. The dividend has been declared from income reserves and is payable on July 29, 2013 to shareholders recorded in the register at the close of business on July 26, 2013.
Kovai Medical Center And Hospital Ltd's Board Recommends Dividend
Kovai Medical Center And Hospital Ltd announced that the Board of Directors of the Company at its meeting held on May 18, 2013, inter alia, has recommended the payment of dividend at the rate of 15% on the equity share capital of the Company (INR1.50 per share) subject to the approval of the shareholders in the ensuing Annual General Meeting.
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  -0.34% |
| Basic Materials | -1.53% |
| Industrials | -1.40% |
| Cyclical Goods & Services | -1.41% |
| Non-Cyclical Goods & Services | -0.71% |
| Financials | -1.66% |
| Healthcare | -0.57% |
| Technology | -0.54% |
| Telecoms | -1.00% |
| Utilities | -0.83% |
| DOW | 15,307.17 | -80.41 |
-0.52% |
| S&P 500 | 1,655.35 | -13.81 |
-0.83% |
| NASDAQ | 3,463.30 | -38.82 |
-1.11% |
| TR US Index | 150.04 | -1.43 |
-0.94% |
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
